####################
# Output from PRIME (v1.0)
# Alleles: B5801
# Affinity predictions: MixMHCpred (/Applications/MixMHCpred-2.1/MixMHCpred)
# PRIME is freely available for academic users.
# Private companies should contact eauffarth@licr.org at the Ludwig Institute for Cancer Research Ltd for commercial licenses.
#
# To cite PRIME, please refer to:
# Schmidt et al. Prediction of neo-epitope immunogenicity reveals TCR recognition determinants and immunoediting in human cancer. Cell Reports Medicine, 2021.
#
####################
Peptide	%Rank_bestAllele	Score_bestAllele	%RankBinding_bestAllele	BestAllele	%Rank_B5801	Score_B5801	%RankBinding_B5801
SITAQPVKI	20.00	0.152584	4.00	B5801	20.00	0.152584	4.00
